Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy
Open Access
- 1 April 2005
- journal article
- clinical trial
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 288 (4) , F637-F641
- https://doi.org/10.1152/ajprenal.00140.2004
Abstract
Increased utilization of cross-sectional imaging has resulted in increased detection of incidental renal tumors. The noninvasive characterization of renal tissue has important implications for the diagnosis of renal malignancies and treatment monitoring. Recently, multiple breath-hold averaged proton magnetic resonance spectroscopy (1H-MRS) performed at high field has enabled the use of this noninvasive metabolic profiling technique for the investigation of the abdomen. Multiple breath-hold averaged1H-MRS at high field (3T) was obtained in the kidneys of 10 healthy volunteers and in renal cell carcinoma tumors of 14 patients. The spectra of normal kidneys showed four main groups of resonances: 1) at 5.4–5.6 ppm, attributed to C6 of cholesterol and the unsaturated parts of the olefinic region of fatty acids; 2) at 4.7 ppm, attributed to the residual water signal; 3) at 3.2 ppm, attributed to trimethylamine moiety of choline metabolites; and 4) at 1.3 and 0.9 ppm, attributed to the methylenes and terminal methyls of lipids. The ratio of the signal at 5.4 ppm to that of 1.3 ppm was 19-fold lower in renal cell carcinomas than in healthy kidneys, tied P = 0.0003 Mann-Whitney U-test, suggesting a decrease in both free cholesterol and the degree of unsaturation of fatty acids in the malignant tissue. This metabolic shift is in agreement with previous ex vivo studies of human renal cell carcinoma. The ability to detect renal metabolic shifts noninvasively may improve the specificity of preoperative renal tissue characterization and may provide a new modality for treatment monitoring.Keywords
This publication has 31 references indexed in Scilit:
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I StudiesJournal of Clinical Oncology, 2003
- Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Administration Propeukin Program Cooperative GroupJournal of Clinical Oncology, 2003
- Breathhold abdominal and thoracic proton MR spectroscopy at 3TMagnetic Resonance in Medicine, 2003
- Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal CancerJournal of Clinical Oncology, 2003
- 1H‐NMR and 13C‐NMR lipid profiles of human renal tissuesBiopolymers, 2003
- Differential routing of choline in implanted breast cancer and normal organsMagnetic Resonance in Medicine, 2001
- Analysis of micellar and vesicular lecithin and cholesterol in model bile using1H- and31P-NMRMagnetic Resonance Materials in Physics, Biology and Medicine, 1995
- Immunotherapy of renal cell carcinomaCA: A Cancer Journal for Clinicians, 1993
- Nuclear magnetic resonance spectroscopy to determine the micellar cholesterol in human bileFEBS Letters, 1992
- Spatial Localization in NMR Spectroscopy in VivoAnnals of the New York Academy of Sciences, 1987